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Abstract 
Glycosylation of flagellins is a well recognized 
property of many bacterial species. In this study 
we describe the structural characterization of novel 
flagellar glycans from a number of hypervirulent 
strains of C. difficile. We used mass spectrometry 
(nano LC- MS and MS/MS analysis) to identify a 
number of putative glycopeptides which carried a 
variety of glycoform substitutions each of which 
was linked through an initial HexNAc residue to 
Ser or Thr. Detailed analysis of a LLDGSSTEIR 
glycopeptide released by tryptic digestion, which 
carried two variant structures, revealed that the 
glycopeptide contained, in addition to 
carbohydrate moieties, a novel structural entity. A 
variety of Electrospray-MS strategies using Q-
TOF technology were used to define this entity, 
including positive- and negative-ion collisionally 
activated decomposition (CAD) MS/MS which 
produced unique fragmentation patterns, and high 
resolution accurate mass measurement to allow 
derivation of atomic compositions, leading to the 
suggestion of a Taurine-containing peptidylamido-
glycan structure. Finally NMR analysis of flagellin 
glycopeptides provided complementary 
information. The glycan portion of the 
modification was assigned as α-Fuc3N-(1!3)-α-
Rha-(1!2)-α-Rha3OMe-(1!3)-β-GlcNAc-
(1!)Ser and the novel capping moiety was shown 
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to be comprised of Taurine, Alanine, and Glycine. 
This is the first report of a novel O-linked 
sulphonated peptidylamido-glycan moiety 
decorating a flagellin protein.   
Introduction 
The intestinal pathogen Clostridium difficile is the 
leading cause of antibiotic-associated diarrhea 
worldwide. The pathogen colonizes the gastro-
intestinal tract when the normal microbiota is 
disturbed after antibiotic treatment, causing C. 
difficile infection (CDI) in susceptible patients. In 
the past decade, CDI mortality has increased 
dramatically since the emergence of hypervirulent 
strains such as the PCR ribotype (RT) 027 and 023 
lineages (1,2).  
The reasons for the increase in severity of CDI 
caused by hypervirulent strains are still not well 
understood. Molecules implicated in C. difficile 
virulence include the secreted toxins TcdA and 
TcdB, and a variety of cell surface biopolymers (3-
6). Amongst the latter, flagella, which are 
responsible for the pathogen’s motility, are 
believed to have roles in virulence because 
disruption of their biosynthesis and expression 
affects colonisation, biofilm formation and toxin 
production (7). 
The flagellin proteins of C. difficile are known to 
be post-translationally modified with O-linked 
glycans and there is evidence that glycosylation 
can affect motility and virulence (8,9). Flagellin 
O-glycosylation is widespread in Gram negative 
bacteria (10) but so far has only been found in 
three Gram positive genera, Clostridium, Listeria 
and Paenibacillus (11-13). A great deal of 
diversity exists amongst flagellin glycans but there 
are some common themes. For instance, many 
Gram negative flagellins have a single 
pseudaminic acid or legionaminic acid residue at 
each of their O-glycosylation sites. These sugars 
can be substituted with a variety of functionalities 
such as acyl and acetamido groups resulting in 
considerable structural heterogeneity. 
Interestingly, the first Clostridium species to have 
its flagellin glycosylation characterised, 
Clostridium botulinum, was found to share this 
type of glycosylation. Thus, its flagellin is 
substituted with the legionaminic acid derivative 
7-acetamido-5-(N-methyl-glutam-4-yl)-amino-
3,5,7,9-tetradeoxy-D-glycero-alpha-D-galacto-
nonulosonic acid (alphaLeg5GluNMe7Ac)(12) In 
contrast, C. difficile post-translational 
modifications appear to be quite different in 
structural composition from those which have been 
found in Gram negative organisms. 
The best characterized C. difficile flagellin is that 
from the first strain to have its genome sequenced 
(14). This PCR-ribotype 012 strain (630) was 
isolated from a Swiss hospital patient in 1982. It is 
an epidemic, multidrug-resistant strain and pre-
dates the emergence of the hypervirulent strains. 
The 630 flagellin is modified at up to seven sites 
with the monosaccharide N-AcetylGlucosamine 
(GlcNAc) which is substituted with a 
phosphodiester-linked N-methyl-L-Threonine 
residue (8,9). RT027 and RT023 strains, however, 
appear to lack this unusual amino acid 
modification. Preliminary data from mass 
spectrometric (MS) investigations of RT027 
flagellins was interpreted as consistent with the 
presence of HexNAc-linked oligosaccharides up to 
pentasaccharide in length. Mass increments in the 
MS data were attributed to various compositions 
of deoxyhexose, methylated deoxyhexose, 
HexNAc and heptose, but full structures were not 
defined at that time because of technological 
limitations (8).  
In this study, we have rigorously characterized 
flagellin glycosylation in several emerging 
hypervirulent clonal strains including RT027, 
RT023, RT106 and RT001. We have discovered 
several variants of a novel peptidylamido-glycan 
sulphonate structure decorating hydroxyamino 
acids (Ser and Thr) in the flagellin (FliC) protein. 
Here we describe the chemical characterization of 
this newly discovered structure using Q-TOF 
technology (15,16) applied in a variety of structure 
elucidation strategies (17,18) including positive- 
and negative-ion collisionally activated 
decomposition (CAD) MS/MS to produce unique 
and interpretable fragmentation patterns, and high 
resolution accurate mass measurement to allow 
derivation of detailed atomic compositions, then 
confirming and extending the structural 
interpretations of the MS data by purifying a 
number of glycopeptides in sufficient quantities to 
define each structure by NMR.  
Results 
Mass Spectrometric Analysis of Flagellin 
Glycopeptides 
A preliminary structure of RT027 flagellin 
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glycosylation had been previously studied by LC-
MS/MS analysis (8) but full structures were not 
solved due to technical limitations. In the study 
presented here, following nano LC-MS and 
MS/MS analysis, a number of putative 
glycopeptides derived from RT0207 and other 
flagellins were identified via a search for oxonium 
ions (eg m/z 204) in the data sets. This led to the 
discovery of a number of glycopeptide candidates 
carrying a variety of glycoform substitutions 
including the peptides LLDGSSTEIR, 
VALVNTSSIMSK and QMVSSLDVALK. Each 
of these peptides carried a glycan modification 
which was linked through an initial HexNAc 
residue to Ser or Thr followed by 
deoxyHex/MethyldeoxyHex and 
MethyldeoxyHex/deoxyHex and 
MethyldeoxyHex/MethyldeoxyHex in positions 2 
and 3 respectively. The majority of structural work 
reported here has concentrated on the 
LLDGSSTEIR glycopeptides from strain R20291, 
and interestingly, two variant structures carried on 
this peptide were present in the LCMS 
chromatograms at m/z 9982+ and 9912+ where the 
MS/MS fragmentation pattern clearly showed (in 
addition to carbohydrate moieties) the presence of 
a novel structural entity not previously observed in 
sugar or amino acid chemistry.  
The collisionally activated decomposition (CAD) 
MS/MS spectra of m/z 9982+ and 9912+  molecules 
are shown in Figure 1, with the main spectrum 
showing the high resolution data (to 4 decimal 
places) for the larger molecule (m/z 9982+), and 
inset showing the low resolution spectrum of m/z 
9912+ for comparison. From these data, it is clear 
that a HexNAc-methyldeoxyHex-deoxyHex- 
glycosyl substituent is attached to the peptide 
backbone (seen at 1090, M+H+) via signals at m/z 
1293, 1453, and 1599 respectively (corresponding 
to glycosidic cleavages), together with a series of 
y’’ ions beginning at m/z 749 and extending with 
the same substituents, identically for both 
precursor ions. A further less intense signal is 
present at m/z 1744 in the high-resolution data 
extending the glycosylation sequence by an amino-
dideoxyHex unit. The high resolution mass 
measurement of the 9912+ signal compared with 
the 9982+ signal shows that the 14 amu mass 
difference corresponds to a CH2  difference 
between the two structures. The clearly novel 
aspect of these glycopeptides can be seen in the 
substantial fragment ions at m/z 396, 378, 268, 
251, 223 and 152 which do not immediately 
correlate with sugar or amino acid origin. The 
equivalent signals are present in the 9912+ data 
(inset spectrum) 14 Da lower at m/z 382, 364, 254, 
237, 209 except for m/z 152 (same), showing that 
the 14 Da mass difference resides between the 152 
and 396/382 fragments in the structure. When 
cross-correlating the observed 396/382 and 1599 
signals with the molecular masses observed in the 
9982+/9912+ quasimolecular ions then these 
fragments are additive to the molecular mass 
(allowing for hydrogen transfers) and thus 
represent between them the overall glycopeptide 
structure, as shown schematically in Figure 1 for 
the 9982+ variant.  
The interpretation of the mechanisms leading to 
these fragment ions was greatly assisted by the 
atomic compositions determined from the accurate 
masses in the high resolution Q-TOF data (see 
representative data in Table 1) and also by the 
presence of “counterion” data, as is often observed 
in doubly charged MS/MS spectra. For example, 
the aminodideoxyHex residue extension from 
m/z1599 to 1744 must therefore be present in the 
m/z 396 counterpart, and its partial loss (128Da) 
by beta-elimination is observed to give m/z 268 in 
Figure 1, whereby the amino function is retained 
by the 268 ion, which itself then loses first 
ammonia to m/z 251and then carbon monoxide to 
m/z 223 from the amide group thus assigned. The 
charge can of course be retained for a proportion 
of fragments on the “counterion” instead of m/z 
268 which would be present at m/z 129 from the 
elimination mechanism. The significant signal at 
m/z 111 (C6H7O2) was assigned to that origin via 
loss of water to give a highly stable triply 
conjugated cyclic ion, available without 
rearrangement by postulating a 3-amino 
substitution. The next significant ion in the low 
mass region is seen at m/z 152 and it was 
recognised that the observed accurate mass 
difference of 71.037 Da (223.0753 minus 
152.0383), could correspond to either an Alanine 
or its isomer N-methyl Glycine (atomic 
composition C3H5NO, theoretical mass 71.0371). 
In mechanistic terms, the carbonyl of such a unit 
could be forming the amide linkage to the amino 
sugar in m/z 396 which would predictably 
fragment to give the 268, 251 (b2) and 223 (a2) 
ions and then to give a terminal “b1” ion at m/z 
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180 (from loss of Ala or N(Me)Gly) the signal for 
which is not observed. However, the m/z 152 mass 
is 28 Daltons (CO from the atomic composition) 
below this mass and it is very common for the a1 
ion subfragment (an aldimine) to be the more 
intense ion in peptide fragmentation, particularly if 
the Nitrogen is alkylated by methyl or another 
grouping giving rise to a tertiary Nitrogen. The 
summary of the interpretation logic used to assign 
the above MS signals at that stage of the study is 
shown in Scheme 1. 
The m/z 152 signal was found to possess an 
unusually mass-deficient accurate mass which 
suggested a sulphur-containing atomic 
composition determined as C4H10NO3S for this 
terminal fragment, which is not the formula of any 
previously reported protein- or carbohydrate-
derived structural unit. In order to help define this 
fragment in more detail, and to provide supporting 
evidence for the ideas in Scheme 1 two further 
sets of experiments were carried out on the 
remaining small quantities of material: (a) MS/MS 
analysis of several of the key fragment ions above 
to confirm mechanistically understandable 
breakdown products and (b) experiments in the 
negative ion MS and MS/MS modes to look for 
new and complementary fragment ion information.  
CAD MS/MS of the cone voltage induced m/z 152 
from the 9912+ and 9982+ glycopeptide samples 
gives rise to two principal ion species seen in 
Figure 2 at m/z 108 (C2H6NO2S) and m/z 70 
(C4H8N) suggesting two overlapping component 
fragments (a sulphonic acid and an alkylamine) 
competitively derived from the m/z 152 ion 
(C4H10NO3S). The negative ion CAD MS/MS 
spectrum obtained for m/z 9962- is shown in 
Figure 3. Firstly, these data confirm the basic 
structural features of the novel glycosylation 
inferred from the positive ion data in Figure 1 and 
shown in Scheme 1 regarding expected principal 
fragments at m/z 921, 718, 540, 394, 266, 180 and 
150, with m/z 718 for example corresponding to 
X-aminodideoxyHex-deoxyHex-methyldeoxyHex-
. Some other signals are derived from the carrier 
peptide LLDGSSTEIR but, importantly, a new 
fragment ion, (with the equivalent not being 
observed in the positive ion MS/MS), is seen at 
m/z 124, and this was recognised as corresponding 
to the mass of aminoethyl-sulphonic acid, Taurine 
(C2H6NO3S, M-H-). The MS/MS of this 9962- - 
derived signal gave rise to an identical MS/MS 
spectrum (Figure 4) to that observed for a 
synthetic sample of Taurine itself, being mainly a 
SO3-. fragment ion base peak, thus providing 
strong evidence for this structural unit within the 
m/z 152 ion in the novel structure.  
Further experiments involving subfragment 
MS/MS, and also hydrogen/deuterium exchange to 
count heteroatom-linked protons, were carried out 
to validate the structural conclusions from the 
mass spectrometric experiments (data not shown), 
but as seen in the structural summary in Scheme 1 
an ambiguity nevertheless remains in the proposed 
novel m/z 268 unit whereby although the amide-
linked aminoacid to the aminodideoxyHex would 
be Glycine in the 9912+ structure, it could be either 
Alanine or N-methyl Glycine in the 9982+ 
structure. There are also several possible ways of 
arranging the R, R1 and R2 atoms in the unit 
incorporating the aminoethyl sulphonic acid-
containing 152 (180) structure, including variants 
containing Taurine itself or Cysteic acid with 
alkylations, to produce the necessary accurate 
masses observed thus satisfying the atomic 
compositions determined from high resolution 
mass measurement. To fully characterize the R-
groups in Scheme 1 and to define the 
stereochemistry and linkages, a scaled-up 
preparation of flagellin was made which was used 
to then allow the isolation of sufficient material for 
the derivation of NMR data. 
NMR Analysis of flagellin glycopeptides 
Flagellin protein (15mg) was extensively digested 
with Proteinase K to enable purification of 
sufficient quantities of glycan material with 
minimal peptide backbone for NMR structural 
analysis. This proteinase K digested material was 
subjected to fractionation to obtain glycan 
enriched material using size exclusion (Biogel 
P10) chromatography followed by Zorbax C18 
reverse phase. All fractions were analysed by 1H 
NMR to identify fractions containing glycopeptide 
material. Three fractions were obtained following 
chromatographic separation which contained 
sufficient amounts of glycopeptide for further 
structural characterisation. Fraction 21 from the 
initial Zorbax C18 column separation contained a 
mixture of two glycan species (compounds 1 and 
2, Figure 5). Fractions 23 and the re-separated 
fraction 12 contained compounds 2 and 3 (Fig 5).  
 2D NMR spectra (COSY, TOCSY, 
ROESY, 1H-13C HSQC, HMBC, and HSQC-
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TOCSY were recorded for all glycopeptide 
fractions. Spectra of fraction 21 (Table 2) 
contained spin-systems of α-Rha3OMe (A, B), β-
GlcNAc (C), two Serine and one Threonine 
residues. The position of the methyl group on 
Rha3OMe was determined from HMBC 
correlation between Me and H/C-3 of this sugar. 
The sequence of the monosaccharides followed 
from NOE and HMBC correlations between H-1 
of residue B to H/C-2 of the residue A, and 
between H-1 of A to H/C-3 of β-GlcNAc C. H-1 
of GlcNAc C showed NOE correlation to Ser* H-3 
and HMBC correlation to Ser* C-3, indicating that 
β-GlcNAc was linked to O-3 of a Serine residue 
(Ser*). Thus the oligosaccharide 1 had the 
structure shown in Fig. 5. The purified 
glycopeptide contained two Serine residues and 
one Threonine residue. 
 Another glycopeptide fraction obtained 
after re-separation contained a mixture of 
compounds 2 and 3 (Figure. 5). Compound 2 
contained all components of the oligosaccharide 1 
without an O-Me-group on O-3 of the terminal 
Rha, and additionally a residue of 3-amino-3,6-
dideoxy-α-galactopyranose (Fuc3N), acylated at 
the aminogroup with the unusual sulphopeptide. 
The position of Fuc3N at O-3 of the Rha E 
followed from NOE and HMBC correlations 
F1:E3. The glycopeptide contained three 
components: Taurine, Alanine, and Glycine. The 
sequence of these components was determined 
based on the following observations: Glycine C-2 
was observed at its usual place around 44ppm 
providing clear evidence that it was acylated by 
the Alanine moiety. In contrast, the low field 
position of the Ala C-2 at 57.5 ppm indicated that 
its NH group is alkylated, (rather than if it was 
within a peptide where the normal field position 
would be ~ 51 ppm). This provides evidence that 
the Taurine unit (deduced from the independent 
mass spectrometric analysis) is linked to the 
Alanine, and that Glycine would be acylating N-3 
of Fuc3N, supporting the interpretation of the mass 
spectrometric data. The sequence of the 
sulphopeptide would then be Taurinyl-Ala-Gly as 
indicated in Figure 5 (Compound 2). 
 Another component of this fraction was 
compound 3, which had the same sugar structure 
as compound 1 but was linked to a Threonine 
residue. The 1H and 13C NMR data for the 
glycopeptides present in fraction 21 is shown in 
Table 2 and Table 3 and the HSQC spectrum 
shown in Figure 6.   
 This NMR data show that the R2 group in 
Scheme 1 of the mass spectrometric interpretation 
is a methyl group (thus allowing an Alanine 
assignment) to give an Ala-Gly dipeptide, with R 
being a hydrogen and R1 the ethyl sulphonic acid 
group giving rise to Taurine in the MS/MS 
fragmentation. The 13C chemical shifts observed 
were in good agreement for an alkylated NH-
group in the Alanine unit and with the shifts 
reported for Taurine 
[http://www.bmrb.wisc.edu/metabolomics/mol_su
mmary/show_data.php?molName=taurine&id=bm
se000120&whichTab=1]. The glycan portion of 
the structure, assigned mass spectrometrically as 
an amino-dideoxyHex-deoxyHex-
methyldeoxyHex-HexNAc- unit in Figure 1 was 
then further assigned from the NMR data as α-
Fuc3N-(1!3)-α-Rha-(1!2)-α-Rha3OMe-(1!3)-β-
GlcNAc-(1!)Ser. The overall structure of the 
“991” peptidyl-glycan is shown as compound 2 in 
Figure 5, and our mass spectrometric data 
suggests that the corresponding “9982+” peptidyl-
glycan will have either Alanine or N-methyl 
Glycine replacing the Glycine in the dipeptide 
portion of that structure producing the observed 14 
mass unit shift. Although the NMR spectra of 
compounds 2 and 3 contained additionally a minor 
methyl group signal, at 3.21/55.1 ppm, which may 
be responsible for the observed mass increase of 
14 amu in the mass spectrum of some 
glycopeptides (“998”), we were unable to assign 
the position of this methyl group within the 
structure. 	
Discussion 
Glycosylation is a key modification of proteins 
and lipids that is often important in intermolecular 
and intercellular interactions. Bacterial protein 
glycosylation systems have come under enhanced 
scrutiny because of the increasing association with 
pathogenic species. Recent research is providing 
compelling evidence for protein glycosylation 
being central to the survival and pathogenesis of 
many bacteria. They have been described 
variously as being important in adhesion, motility, 
DNA uptake, biofilm formation, autoaggregation, 
invasion, serum resistance, immune evasion and 
animal colonization (19-25) (1-7). Recently, the 
structure and biological role of flagellar 
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glycosylation in the enteric opportunistic pathogen 
C.difficile 630 has been described (8,9). Moreover, 
investigations into the biological role of flagellar 
glycosylation in the emerging hypervirulent 
C.difficile RT027 and RT023 have been 
undertaken and reported in our accompanying 
paper(26). In both C.difficile studies, flagella post-
translational modification plays a role in motility, 
aggregation and adhesion to abiotic surfaces. In 
the case of C.difficile RT027 flagella glycosylation 
is also involved in Caco-2 cell adhesion. In the 
present study, we have revealed the discovery of a 
unique flagellar non-reducing end peptidylamido-
glycan structure on glycoproteins isolated from 
RT027 and others (RT023, 001 and 106). 
Following the mass spectrometric discovery of 
unusual post-translational modifications (PTMs) in 
the LC-MS and MS/MS data from tryptic digests 
of the FliC protein using an instrument tuned for 
optimal automated information-dependent 
acquisition, a full battery of advanced MS 
techniques (15-18)  was first applied to 
characterise the novel components to the extent 
possible on the small quantities of protein 
available. These included the production of on-line 
high-resolution MS/MS data using a 40,000 
resolving power Q-TOF geometry instrument (see 
Experimental Procedures) allowing the assignment 
of probable atomic compositions of all fragment 
ions, including those clearly not derived from 
normal glycopeptides or previously reported 
PTMs. These experiments showed for the first 
time the presence of sulphur-containing moieties, 
and subsequent MS2 and MS3 data generated by 
the high sensitivity and mass accuracy of the Xevo 
Q-TOF geometry instrument (15,16) in both 
positive and negative ion mode allowed the 
discovery of a Taurine (aminoethyl-sulphonic 
acid) unit in the breakdown fragments of several of 
the precursor ion species investigated. Combining 
all of these data sets, together with confirmatory 
experiments such as Hydrogen/Deuterium 
exchange analysis (not shown), allowed the novel 
structural unit containing the sulphonic acid group 
to be defined as shown in Scheme 1 (with 
composition C4H10NO3S). When it then became 
possible to isolate sufficient of the des-methyl 
(9912+) variant of the structure, a detailed NMR 
study was used to reveal the identity of the R, R1 
and R2 groups shown to give the overall PTM 
structure in Figure 5. Our mass spectrometric 
studies on hypervirulent strains Ribotype 027, 023, 
106 and 001 have shown the presence of one of 
these structures (“9912+” or “9982+”) and related 
variants (data not shown) in each of the strains 
studied. The work reported here has concentrated 
on what was found to be the most abundant 
LLDGSSTEIR tryptic glycopeptide, but 
preliminary mass spectrometric analysis shows 
that similar modifications are present on at least 
two other flagellin peptides, QMVSSLDVALK 
and VALVNTSSIMSK. Only minor amounts of 
the respective free (non-glycosylated) peptides 
were found in the digests.  
In contrast to this very complex glycosylation of 
the flagella of C.difficile RT027, the 630 type 
strain is modified with single GlcNAc residues 
that are substituted with an N-methylated 
Threonine linked via a phosphodiester bond (8,9). 
Despite the substantial differences in 
glycosylation, a common feature is the presence of 
a negatively charged functionality in the periphery 
of the post-translational modification, namely a 
sulphonate in the hypervirulent strains and a 
phosphoester in the 630 strain. These charged 
groups are likely to be involved in ionic 
interactions between the flagella and extracellular 
structures. This could explain the phenotype of C. 
difficile flagellar glycosylation knockouts where 
autoaggregation, biofilm formation and adhesion 
to Caco-2 cells are reduced (9,26).  
An increasing number of reports on flagellar 
glycosylation on Gram-positive and Gram-
negative bacterial pathogens have been published 
(10,27). In comparison with Gram-negative 
bacteria, the reports on flagellar glycosylation on 
Gram-positive are limited. Among Gram-positive, 
Clostridium spp. are the most characterised 
(8,9,28-30). There are two other genera of Gram-
positive pathogens with O-glycosylated flagella: 
Listeria and Paenibacilla. Listeria monocytogenes 
is glycosylated at up to six sites per monomer with 
a single β-O-linked GlcNAc residue (11). 
Paenibacilla has a flagella modified with an O-
linked trisaccharide comprised of one hexose and 
two-N-acetyl-hexosamine residues, at three sites of 
glycosylation(13). In the case of Gram-negative 
bacteria, the diversity of flagellar glycosylation 
moieties is remarkable. Flagellins of many Gram-
negative bacterial pathogens have a single 
pseudaminic or legionaminic acid residue at each 
of their O-glycosylation sites(10). Both these 
Clostridium difficile type B flagellin is glycosylated with sulphonated peptidylamido-glycans 
 
7 
 
sugars exhibit considerable diversity due to 
differences in acyl functionalities. Notably some 
are acylated with amino acids. Thus, Glycine and 
N-Acetyl Glutamine have each been observed as 
ester-linked substituents of pseudaminic acid in the 
flagella of Aeromonas caviae and Campylobacter 
jejuni, respectively (31). However there are no 
reports of peptidyl substituents on glycans from 
gram negative organisms. In addition, amino acid 
substituents have not previously been observed on 
the glycans of gram positive pathogens. Therefore 
our discovery that the C.difficile RT027 flagella 
are modified by a peptidylamido-sugar moiety is a 
unique finding within both Gram-positive and 
Gram-negative bacteria.  
Another structural component, identified in the 
present study as a Taurine-like non-reducing end 
unit, is unique in flagella glycosylation from 
bacteria. This unit might be used by RT027 strains 
as a strategy to evade the host immune system as 
Taurine is reported to have a key role in the 
regulation of the innate immune response (32). 
In some bacterial pathogens such as the enteric 
pathogen Campylobacter jejuni, 
glycosyltransferases and glycan biosynthetic genes 
are situated adjacent to biosynthetic flagellar genes 
(33). For C.difficile type B flagellin it appears that 
rhamnose biosynthetic genes (CDR20291_0223-
0226) which are similar to rmlD, rmlA, rmlC and 
rmlB, lie upstream of fliC and are likely involved 
in the biosynthesis of the rhamnose moieties 
modifying the C.difficile RT027 flagella (26). 
Within the locus immediately downstream of fliC 
in addition to the three putative flagellar GT genes, 
there are a number of biosynthetic genes 
(CDR20291_0244-0247) which appear to be 
responsible for synthesis of the novel terminal 
moiety (26). These biosynthetic genes are present 
in the genomes of both RT027 and RT023 strains. 
The amino acid similarity of CDR20291_0247 to 
FdtB from A. thermoaerophilus suggests that this 
gene product is likely involved in the production 
of the FucN monosaccharide. Previous work using 
Aneurinibacillus thermoaerophilus and 
Xamthomonas. campestris enzymes have shown 
that RmlA and RmlB catalyze the first two steps 
for 3-amido-3,6-dideoxygalactose (FucN) 
biosynthesis(34) by producing the substrate dTDP-
6-deoxy-D-xylohex-4-ulose. Optimally, this 
substrate would be converted to dTDP-6-deoxy-D-
xylohex-3-ulose by FdtA, however it has been 
demonstrated that incubation of the 4-keto product 
with FdtB and cofactors will yield a moderate 
level of conversion to dTDP-Fucp3N in the 
absence of FdtA isomerase (34). It has been 
suggested that this may be due to production of 3-
keto substrate via a non enzymatic processes (35). 
As no homolog of FdtA appears to be present in 
the C. difficile R20291 type B post-translational 
modification locus it appears that this may be the 
mechanism whereby limited amounts of FucN can 
be produced in C. difficile and incorporated into 
the flagellar glycan. The heterogeneity observed in 
flagellin glycan composition (sulphonated 
peptidylamido-glycan structure and truncated 
methylated trisaccharide (Rha-Rha-GlcNAc) 
structure) might be explained by the inefficient 
production of FucN from dTDP-6-deoxy-D-
xylohexose-4-ulose by FdtB. A limiting amounts 
of FucN would prevent the synthesis of the full 
flagellar glycan. In addition to the FdtB homolog 
there exists a putative acyltransferase 
(CDR20291_0244) which is a candidate for 
acylating the amino group of the fucosamine 
moiety. Downstream of CDR20291_0244 lie 
CDR20291_0245, CDR20291_0246 which are co-
transcribed with the GT genes and encode a 
putative D-alanine ligase and alanine 
dehydrogenase, respectively. These genes are 
likely involved in the biosynthesis of the peptidyl 
moiety of this novel flagellar glycan (26). 
 
This study reveals a unique flagellar glycosylation 
structure in the bacterial pathogen C. difficile 
hypervirulent RT027 strains which could provide 
the organism with a novel strategy to escape the 
immune system and be more virulent. 
Furthermore, this work highlights the diversity of 
glycans modifying flagella in other hypervirulent 
C.difficile RT such as RT023, RT001 and RT106 
which could suggest different strategies of 
C.difficile to evade the immune system.  
. 
Experimental Procedures 
Bacterial growth and Cultures - C. difficile 
strains, used in this study, are shown in Table 4. 
Strains were routinely grown on Brazier’s CCEY 
agar (BioConnection, Leeds, United Kingdom) 
containing 4% [wt/vol] egg yolk,  250 mg/ml 
cycloserine, 8 mg/ml cefoxitin (Bioconnections, 
Leeds, UK) and 1% defibrinated horse blood (TCS 
Biosciences, Buckingham, UK), in blood agar 
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(Oxoid, Hampshire, UK) and in BHI (brain heart 
infusion media [Oxoid, Hampshire, UK]) and 
BHIS (BHI supplemented with 0.5% w/v yeast 
[Sigma, Gillingham,UK], 0.1% L-Cysteine 
[Sigma, Gillingham, UK]) broth or agar. All 
cultures were incubated at 37 °C overnight in a 
Don Whitney MG500 anaerobic workstation (Don 
Whitney Scientific Ltd). 
Protein Isolation and Digestion - Bacteria were 
grown on BHIS overnight, at 37 °C. C. difficile 
strains were harvested, washed in phosphate 
buffered saline and resuspended in a 1:100 volume 
of low-pH glycine (0.2 M glycine-HCl, pH 2.2) 
and incubated at room temperature for 30 min with 
gentle shaking. The cells were removed by 
centrifugation at 4 °C and the supernatant 
neutralized with the addition of 2 M Tris to a pH 
of 7 to 8. Flagellin preparations were analysed by 
12% SDS-PAGE Novex® NuPAGE® tris-glycine 
SDS-PAGE. The separated proteins were stained 
with coomassie in accordance with standard 
techniques. Flagellin bands were excised 
lyophilized and digested with trypsin 
(E.C.3.4.21.4, Promega) overnight. Peptides were 
extracted from gel pieces and studied by-LC-
MS/MS analysis. 
Mass Spectrometry - Positive Ion Q-TOF 
technology (15,16) was used to study the tryptic 
digests of proteins isolated from the various strains 
of C. difficile ribotypes in LC-MS and MS/MS 
experiments conducted on several instruments.  A 
Sciex QStar Pulsar 1 instrument with LC Packings 
nanoLC using a C-18 nanocapillary (75 micron x 
15 cm Pepmap) column eluting with a 0.05% 
formic acid/5%-95% acetonitrile gradient over 90 
min, and information dependent acquisition (IDA) 
data acquisition was used for the low resolution 
(5000 resolving power) analysis of digest 
mixtures.  A Waters XevoG2 instrument with 
Acquity microbore UPLC using a C-18 (1mm x 
50mm BEH) column eluting with a 0.1% formic 
acid/0%-85% acetonitrile gradient over 40 min, 
with data dependent acquisition (DDA) 
acquisition, was used for detailed positive- and 
negative-ion MSn and cold isotope labelling 
experiments, and a Waters Synapt G2-S, with 
nanoAcquity UPLC and a 75 micron x 15 cm BEH 
column and gradient elution with 0.05% formic 
acid/5%-95% acetonitrile over 45 min, and DDA 
data acquisition, was used for the collection of the 
High Resolution (40,000 resolving power) MS/MS 
data from which atomic compositions could be 
calculated. MS3 data was generated on the XevoG2 
instrument on various fragment ions of interest by 
nanospray of 1-2 microlitres of LC-collected 
fractions loaded into borosilicate needles, using 
high cone voltage to achieve source fragmentation, 
then passing the fragment ions of interest into the 
collision cell for CAD MS/MS. 
Negative Ion mass spectrometry was used 
to study collected fractions of interest. These were  
adjusted to basic pH using 10% ammonia, then 
MS3 data was generated on the XevoG2 instrument 
on various fragment ions of interest by nanospray 
as described above. 
NMR glycan structural analysis - Large scale 
preparation of flagellin was made by growing C. 
difficile R20291 overnight on 40 BHIS agar plates 
at 37 oC in an anaerobic chamber. Cells were 
harvested into sterile distilled water (dH2O) and 
cells were vortexed for 3 min to release flagella 
filaments from cells. Bacterial cells were removed 
by centrifugation at 13,000 RPM in an Eppendorf 
centrifuge for 5 min (x2). The supernatant was 
collected, pooled and passed through a 13mm 
PVDF filter. This sterile supernatant was then 
centrifuged at 55,000 rpm for 1 h at 4 oC in a 
Beckman Optima TLX Ultracentrifuge using a 
Beckman TLA 120.2 rotor. The pelleted material 
was resuspended in dH2O and the 
ultracentrifugation step was repeated. The 
supernatant was discarded and the pellet 
resuspended in dH2O. Flagellin protein was 
obtained from multiple bacterial growths (>10) to 
give a total of 10 mg flagellin protein at a 
concentration of 0.4mg/ml (as determined by 
Biorad Protein Assay). To obtain glycan material 
devoid of protein backbone for structural analysis, 
flagellin (10 mg) was digested with proteinase K at 
a ratio of 1:1 (Sigma) in 10mM Na2PO4 pH 7.6 at 
37 oC for 48 h. The proteinase K digested material 
was lyophilized, resuspended in dH2O and the 
sample fractionated by gel filtration on a Biogel 
P10 column (2.5x80 cm, 1% Acetic acid, RI 
detector). Each fraction was analyzed by 1H NMR 
and the glycopeptide-containing fraction was then 
applied to a Zorbax C18 column in 0.1% TFA-
80% acetonitrile gradient with UV detector at 220 
nm and fractions collected and reexamined by 1H 
NMR for presence of glycan. Separation was then 
repeated with selected fractions using a gradient 
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from 4 to 20% of 80% acetonitrile over 1 h. All 
fractions were then analyzed by NMR. 
NMR spectroscopy: NMR experiments 
were carried out on a Bruker AVANCE III 600 
MHz (1H) spectrometer with 5 mm Z-gradient 
probe with acetone internal reference (2.225 ppm 
for 1H and 31.45 ppm for 13C) using standard pulse 
sequences cosygpprqf (gCOSY), mlevphpr 
(TOCSY, mixing time 120 ms), roesyphpr 
(ROESY, mixing time 500 ms), hsqcedetgp 
(HSQC), hsqcetgpml (HSQC-TOCSY, 80 ms 
TOCSY delay) and hmbcgplpndqf (HMBC, 100 
ms long range transfer delay). Resolution was kept 
<3 Hz/pt in F2 in proton-proton correlations and 
<5 Hz/pt in F2 of H-C correlations. The spectra 
were processed and analyzed using the Bruker 
Topspin 2.1 program.
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Table 1: Atomic compositions deduced for key signals in the high resolution MS/MS data. 
This table shows the deduced atomic compositions for the experimental (measured) masses observed for 
key signals in the high resolution MS/MS data (Fig 1) together with the theoretical masses of those 
compositions. Note that certain fragments, such as peptide y” ions and the peptide quasimolecular ion 
(M+H+) serve as useful internal standards, confirming the mass accuracies across the data set. Key 
discoveries from these data included the finding of sulphur in the m/z 152 and higher mass fragments, 
thus confirming a novel structural unit and allowing the interpretation of a clear fragmentation pathway 
between the m/z 396 and 152 ions. For a full interpretation see the text and Scheme 1. 
 
Observed Mass (m/z) Atomic Composition 
Assigned 
Theoretical Mass (m/z 
111.0441 C6H7O2 111.0446 
152.0383 C4H10NO3S 152.0381 
175.1192 y"1 175.1195 
204.0873 C8H14NO5 204.0872 
223.0753 C7H15N2O4S 223.0752 
251.0700 C8H15N2O5S 251.0701 
268.0965 C8H18N3O5 S 268.0967 
288.2034 y"2 288.2035 
378.1333 C14H24N3O7S 378.1335 
396.1432 C14H26N3O8S 396.1441 
749.3781 y"7 749.3793 
952.4579 Y”7 + HexNAc 952.4587 
1090.5752 Peptide (M + H+) 1090.5745 
1293.6548 Peptide + HexNAc 1293.6538 
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Table 2. NMR data for compound 1. NAc: 175.8; 2.11/23.7 ppm. Me: 3.44/57.2; 3.45/57.7 ppm 
 
Fr. 21 H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6 
RhaMe     
A 
5.08 3.97 3.56 3.50 4.02 1.25 
 100.9 76.8 80.4 72.2 70.2 17.6 
RhaMe     
B 
4.89 4.27 3.45 3.46 3.75 1.29 
 103.5 67.0 80.5 72.2 70.1 18.2 
GlcNAc     
C 
4.67 3.87 3.60 3.54 3.49 3.79; 3.94 
 100.9 56.3 82.9 69.5 77.1 61.7 
Ser*  4.36 4.17; 4.17    
 168.2 54.2 68.0    
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Table 3. NMR data for compounds 2 and 3. Atom numbering in HSO3CH2CH2NH-Ala (X) from Ala side. 
NAc: 175.8; 2.11/23.7 ppm. Me: 3.44/57.2; 3.45/57.7 ppm 
Fr. 21 H/C-1 H/C-2 H/C-3 H/C-4 H/C-5 H/C-6 
RhaMe     
A 
5.08 3.97 3.56 3.51 4.01 1.25 
 101.0 77.1 80.4 72.2 70.3 17.6 
Rha           
E 
4.89 4.21 3.80 3.58 3.80 1.32 
 103.2 68.2 76.9 71.4 70.2 18.3 
GlcNAc     
C 
4.66 3.87 3.60 3.54 3.48 3.77; 3.94 
 100.9 56.3 83.0 69.5 77.1 61.8 
Fuc3NR    
F 
5.09 3.88 4.31 3.78 4.42  
 96.6 67.1 52.4 71.6 68.0  
Ser*  4.36 4.17; 4.17    
  54.2 68.0    
Ala 171.5 4.20 1.61    
  57.5 16.5    
Gly  4.06     
  43.7     
X 3.47; 3.51 3.32; 3.32     
 42.9 47.7     
RhaMe     
B 
4.89 4.27 3.45 3.46 3.74 1.29 
 103.2 67.0 80.5 72.2 70.1 18.2 
RhaMe     
D 
5.09 3.99 3.56 3.51 4.01 1.25 
 100.9 76.5 80.4 72.2 70.3 17.6 
GlcNAc    
C' 
4.62 3.79 3.60 3.50 3.45 3.75; 3.92 
 100.2 56.8 83.0 69.7 77.0 62.0 
Thr*  4.53 4.32    
  59.3 75.9    
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Table 4. Strains used in this study  
Strains Characteristics Source 
Clostridium difficile   
R20291 PCR ribotype 027, isolated 
from an outbreak in 2004-2005 
Stabler et al., 2009 
CD196 ribotype 027,isolated from a 
pseudomembranous colitis case 
France, 1985 
BI-16 PCR ribotype 027, isolated 
from an outbreak in 2004 
Augusta, USA 
CD305 PCR ribotype 023, isolated 
from an outbreak in 2011 
Barts Hospital, UK 
CD1426 PCR ribotype 023, isolated 
from an outbreak in 2010 
Queens Hospital Remford, UK 
CD1714 PCR ribotype 023, isolated 
from an outbreak in 2011 
Whipp's Cross Hospital, UK 
106-01 PCR ribotype 106, isolated 
from an outbreak in 2008 
Fatal case, Glasgow, UK 
001-01 PCR ribotype 001, isolated 
from an outbreak in 2008 
Paisley, UK 
001-07 PCR ribotype 001, isolated 
from an outbreak in 2008 
Edinburgh, UK  
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LEGENDS 
Figure 1: Positive ion on-line nano-LC MS/MS high resolution CAD mass spectrum of m/z 9982+ 
(main picture) with equivalent low resolution MS/MS spectrum of m/z 9912+ (inset). Note the 
low-mass signals (below m/z 400) many of which do not correlate with either known peptide or 
carbohydrate fragments, and which therefore indicated the discovery of novel structural features in 
these glycopeptides. For full interpretation see the text and Scheme 1. 
Scheme 1: Summary of the interpretation and mechanistic logic used to assess the mass spectrometric 
fragmentation data determined in this study (see Fig 1) showing the probable structural assignments. 
Conclusions were aided by the derivation of atomic compositions of key fragments shown in Table 1. 
Figure 2: Positive ion nanospray CAD MS/MS spectrum of m/z 152 produced via cone-voltage 
induced in-source fragmentation of m/z 9982+. Signals at m/z 70 and 108 correspond to losses of 82 
and 44 mass units respectively, and were correlated with the low-mass high resolution data from Fig. 
1 to deduce atomic compositions for these ions of C4H8N and C2H6NO2S. This suggests two 
overlapping fragments derived from the m/z 152 ion (C4H10NO3S in Table 1), an alkylamine and a 
possible sulphonic acid. For a full interpretation see the text and Scheme 1. 
Figure 3: Negative ion nanospray CAD MS/MS spectrum of m/z 9962- (m/z 100-1200 mass 
range). Negative ion fragmentation data complement and expand that from positive ion experiments, 
as here for m/z 394 (equivalent to m/z 396 in Fig.1), m/z 266 (m/z 268), m/z 173 (m/z 175) and m/z 
150 (m/z 152). Interestingly, a moderately intense low-mass fragment was observed at m/z 124 
(lowest mass significant fragment) and this was therefore chosen for further CAD MS/MS analysis – 
see Fig 4. The highest mass signal seen at m/z 921 corresponds to the elimination of the complete 
sulphonated peptidylamido-glycan from the peptide backbone to leave a dehydropeptide (not 
observed).  For a full interpretation see the text. 
Figure 4: The negative ion nanospray CAD MS/MS spectrum of m/z 124 produced via cone 
voltage induced in-source fragmentation of m/z 9962-. The base peak (main signal) observed is 
present at m/z 79.96, interpreted as SO3-. together with minor, less informative signals. This spectrum 
provided the first evidence of the presence of a sulphonic acid group in the new structure. A sample of 
synthetic Taurine was then analysed, showing an equivalent negative ion spectrum with base peak 
m/z 79.96. 
Figure 5:  C. difficile R20291 flagellar glycan compounds. Structures of isolated compound 1, 2 
and 3 are presented. Letters A, B, C, C’, D, E and F below the structures are labelled according to the 
assignment of resonances presented in Fig 6 and Tables 2 and 3.  381 indicates the fragment identified 
by MS analysis in Fig 1 (inset m/z 382). 
Figure 6: Part of the 1H-13C HSQC spectrum of the mixture of compounds 2 and 3. Signal 
marked # probably belongs to a structure 2 with additional Me group, not yet localized. Amino acids 
marked with superscript numbers are from peptide part, sequence not determined. Thr* and Ser* are 
glycosylated. 
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